Similar articles for PMID: 23542011

Year	Number of Results
2004	2
2005	3
2006	4
2007	5
2008	9
2009	4
2010	3
2011	7
2012	7
2013	9
2014	1
2015	6
2016	8
2017	7
2018	8
2019	5
2020	3
2021	1
2022	2
2023	2
2024	0

1

D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B.

McDougle RM, Hultquist JF, Stabell AC, Sawyer SL, Harris RS. McDougle RM, et al. Virology. 2013 Jun 20;441(1):31-9. doi: 10.1016/j.virol.2013.03.003. Epub 2013 Mar 29. Virology. 2013. PMID: 23542011 Free PMC article.

2

Ancestral APOBEC3B Nuclear Localization Is Maintained in Humans and Apes and Altered in Most Other Old World Primate Species.

Auerbach AA, Becker JT, Moraes SN, Moghadasi SA, Duda JM, Salamango DJ, Harris RS. Auerbach AA, et al. mSphere. 2022 Dec 21;7(6):e0045122. doi: 10.1128/msphere.00451-22. Epub 2022 Nov 14. mSphere. 2022. PMID: 36374108 Free PMC article.

3

Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.

Wang J, Shaban NM, Land AM, Brown WL, Harris RS. Wang J, et al. J Virol. 2018 May 29;92(12):e00447-18. doi: 10.1128/JVI.00447-18. Print 2018 Jun 15. J Virol. 2018. PMID: 29618650 Free PMC article.

4

APOBEC3B lysine residues are dispensable for DNA cytosine deamination, HIV-1 restriction, and nuclear localization.

Molan AM, Hanson HM, Chweya CM, Anderson BD, Starrett GJ, Richards CM, Harris RS. Molan AM, et al. Virology. 2017 Nov;511:74-81. doi: 10.1016/j.virol.2017.08.025. Epub 2017 Aug 23. Virology. 2017. PMID: 28841445 Free PMC article.

5

Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.

Land AM, Wang J, Law EK, Aberle R, Kirmaier A, Krupp A, Johnson WE, Harris RS. Land AM, et al. Oncotarget. 2015 Nov 24;6(37):39969-79. doi: 10.18632/oncotarget.5483. Oncotarget. 2015. PMID: 26544511 Free PMC article.

6

Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution.

Schmitt K, Guo K, Algaier M, Ruiz A, Cheng F, Qiu J, Wissing S, Santiago ML, Stephens EB. Schmitt K, et al. Virology. 2011 Oct 10;419(1):24-42. doi: 10.1016/j.virol.2011.07.017. Epub 2011 Aug 25. Virology. 2011. PMID: 21868050 Free PMC article.

7

APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism.

Stenglein MD, Harris RS. Stenglein MD, et al. J Biol Chem. 2006 Jun 23;281(25):16837-16841. doi: 10.1074/jbc.M602367200. Epub 2006 Apr 28. J Biol Chem. 2006. PMID: 16648136 Free article.

8

Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.

Bonvin M, Greeve J. Bonvin M, et al. Curr Opin Infect Dis. 2008 Jun;21(3):298-303. doi: 10.1097/QCO.0b013e3282fe1bb2. Curr Opin Infect Dis. 2008. PMID: 18448976 Review.

9

The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.

Bogerd HP, Wiegand HL, Doehle BP, Cullen BR. Bogerd HP, et al. Virology. 2007 Aug 1;364(2):486-93. doi: 10.1016/j.virol.2007.03.019. Epub 2007 Apr 16. Virology. 2007. PMID: 17434555 Free PMC article.

10

The APOBEC3B cytidine deaminase is an adenovirus restriction factor.

Lejeune N, Mathieu S, Decloux A, Poulain F, Blockx Z, Raymond KA, Willemart K, Vartanian JP, Suspène R, Gillet NA. Lejeune N, et al. PLoS Pathog. 2023 Feb 6;19(2):e1011156. doi: 10.1371/journal.ppat.1011156. eCollection 2023 Feb. PLoS Pathog. 2023. PMID: 36745676 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year